A case of me: clinical cancer sequencing and the future of precision medicine.

about

Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia Clonotyping for precision oncology.The future of cancer treatment using precision oncogenomics.

P2860

Q27853385-AB48C84B-08DC-46B9-BB1C-40777D8A07CE Q38614405-5C865E06-1BB1-4772-9271-7C62A9C63705 Q55243436-FF642A92-CAB1-48F1-8F22-EE2A79F4FC25

P2860

A case of me: clinical cancer sequencing and the future of precision medicine.

Item

http://www.wikidata.org/entity/Q38871220

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A case of me: clinical cancer sequencing and the future of precision medicine.

@en

type

Item

label

A case of me: clinical cancer sequencing and the future of precision medicine.

@en

prefLabel

A case of me: clinical cancer sequencing and the future of precision medicine.

@en

P1476

A case of me: clinical cancer sequencing and the future of precision medicine.

@en

P2093

Lukas D Wartman

http://www.w3.org/2001/XMLSchema#string

P2860

Recurring mutations found by sequencing an acute myeloid leukemia genome

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

DNMT3A Mutations in Acute Myeloid Leukemia

Genomic medicine--an updated primer.

The origin and evolution of mutations in acute myeloid leukemia

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.

First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.

Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia.

P304

a000349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1101/MCS.A000349

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27148564

http://www.w3.org/2001/XMLSchema#string

P932

4850894

http://www.w3.org/2001/XMLSchema#string

A case of me: clinical cancer sequencing and the future of precision medicine.

about

P2860

P2860

A case of me: clinical cancer sequencing and the future of precision medicine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932